Fresenius Medical Care at ASN Kidney Week 2023

November 2-5, 2023
Pennsylvania Convention Center
Philadelphia, Pennsylvania, USA

A doctor and an elderly patient are indoors at the woman's home. The doctor is talking to the woman while holding a tablet computer.

The annual American Society of Nephrology (ASN) Kidney Week symposium is one of the most influential gatherings of kidney professionals in the world. Fresenius Medical Care’s presence at ASN Kidney Week demonstrates our commitment to advance and improve kidney care on a global scale.

Experts from across the company present 64 research abstracts at this year’s meeting. In addition, Fresenius Medical Care representatives will be available on site at the symposium to discuss our research and offerings in the Kidney Week exhibit hall at our three booths:

Fresenius Medical Care (Booth #1505): Fresenius Medical Care provides the most comprehensive product portfolio in dialysis. We continue to improve patient care In-Center, at Home, and in Critical Care environments with the state-of-the-art equipment and world class research and advocacy.
Fresenius Medical Care Renal Pharmaceuticals (Booth #1405): Fresenius Medical Care Renal Pharmaceuticals specializes in the prescription needs of ESRD patients and is dedicated to providing pharmaceuticals to individuals undergoing dialysis treatment.
Frenova (Booth #2319): Frenova, a division of Fresenius Medical Care, is a global contracted research and site management organization dedicated to the success of clinical research. Learn more about Frenova here.

A summary of the Fresenius Medical Care-affiliated presentations happening at this year’s ASN Kidney Week appears below. You can also read the press release about Fresenius Medical Care’s presence at ASN here.

Fresenius Medical Care-Affiliated Presentations at ASN 2023

No.	Author	Title	Source	Paper No.*	FME Affiliation(s)	URL	Full citation
1	Alejos B., Braun J., Rincón A., Croft K., Stauss-Grabo M., Winter A., Stuard S., Baro M.E. and Arkossy O.	Immune Response After the Fourth COVID-19 Vaccine Dose in Hemodialysis Patients	J Am Soc Nephrol 34, 2023: 709-710.	FR-PO1102	Fresenius Medical Care	Read More	Alejos B., Braun J., Rincón A., Croft K., Stauss-Grabo M., Winter A., Stuard S., Baro M.E. and Arkossy O.: Immune Response After the Fourth COVID-19 Vaccine Dose in Hemodialysis Patients [Abstract]. J Am Soc Nephrol 34, 2023: 709-710.
2	Alejos B., Jiao Y., Wolf M., Larkin J.W., Winter A., Chaudhuri S., Stauss-Grabo M., Usvyat L.A., Hymes J.L., Maddux F.W., Wheeler D.C., Stenvinkel P., Floege J. On Behalf of the INSPIRE Core Group	Gastrointestinal Bleeding Types and Associated Mortality Rates in Dialysis Patients	J Am Soc Nephrol 34, 2023: 635.	FR-PO830	Fresenius Medical Care	Read More	Alejos B., Jiao Y., Wolf M., Larkin J.W., Winter A., Chaudhuri S., Stauss-Grabo M., Usvyat L.A., Hymes J.L., Maddux F.W., Wheeler D.C., Stenvinkel P., Floege J. On Behalf of the INSPIRE Core Group: Gastrointestinal Bleeding Types and Associated Mortality Rates in Dialysis Patients [Abstract]. J Am Soc Nephrol 34, 2023: 635.
3	Alejos B., Jiao Y., Wolf M., Larkin J.W., Winter A., Chaudhuri S., Stauss-Grabo M., Usvyat L.A., Hymes J.L., Maddux F.W., Wheeler D.C., Stenvinkel P., Floege J. On Behalf of the INSPIRE Core Group	Mortality After Gastrointestinal Bleeding Among Dialysis Patients	J Am Soc Nephrol 34, 2023: 1080.	PUB113	Fresenius Medical Care	Read More	Alejos B., Jiao Y., Wolf M., Larkin J.W., Winter A., Chaudhuri S., Stauss-Grabo M., Usvyat L.A., Hymes J.L., Maddux F.W., Wheeler D.C., Stenvinkel P., Floege J. On Behalf of the INSPIRE Core Group: Mortality After Gastrointestinal Bleeding Among Dialysis Patients [Abstract]. J Am Soc Nephrol 34, 2023: 1080.
4	Bellocchio F., Garbelli M., Stuard S., Nikam M., Usvyat L.A. and Neri L.	Comparative Prognostic Accuracy of Vascular Access Flow and Artificial Intelligence (AI)-Based Arteriovenous Fistula (AVF) Failure Risk Score	J Am Soc Nephrol 34, 2023: 538.	FR-PO489	Fresenius Medical Care	Read More	Bellocchio F., Garbelli M., Stuard S., Nikam M., Usvyat L.A. and Neri L.: Comparative Prognostic Accuracy of Vascular Access Flow and Artificial Intelligence (AI)-Based Arteriovenous Fistula (AVF) Failure Risk Score [Abstract]. J Am Soc Nephrol 34, 2023: 538.
5	Blankenship D.M., Garrison A.M., Kotanko P., Raimann J.G., Han H., Usvyat L.A., Epstein M., Olaniran K.O. and Maddux F.W.	Association Between Sickle Cell Disease and Mortality and Hospitalizations Among In-Center Hemodialysis Patients	J Am Soc Nephrol 34, 2023: 576.	FR-PO631	Fresenius Medical Care, Renal Research Institute	Read More	Blankenship D.M., Garrison A.M., Kotanko P., Raimann J.G., Han H., Usvyat L.A., Epstein M., Olaniran K.O. and Maddux F.W.: Association Between Sickle Cell Disease and Mortality and Hospitalizations Among In-Center Hemodialysis Patients [Abstract]. J Am Soc Nephrol 34, 2023: 576.
6	Blankenship D.M., Wadhwa N., Green J., Dharmadhikari A.M., Willetts J., Usvyat L.A. and Maddux F.W.	Home Therapy New Patient Experience Survey Assessment for New Home Dialysis Patients	J Am Soc Nephrol 34, 2023: 183.	TH-PO328	Fresenius Medical Care	Read More	Blankenship D.M., Wadhwa N., Green J., Dharmadhikari A.M., Willetts J., Usvyat L.A. and Maddux F.W.: Home Therapy New Patient Experience Survey Assessment for New Home Dialysis Patients [Abstract]. J Am Soc Nephrol 34, 2023: 183.
7	Bregoli A., Bellocchio F., Garbelli M., Stuard S., Nikam M., Usvyat L.A. and Neri L.	Impact of Arteriovenous Fistula (AVF) Dysfunctional and Repeated Endovascular Procedures on AVF Intervention-Free Survival	J Am Soc Nephrol 34, 2023: 538.	FR-PO490	Fresenius Medical Care	Read More	Bregoli A., Bellocchio F., Garbelli M., Stuard S., Nikam M., Usvyat L.A. and Neri L.: Impact of Arteriovenous Fistula (AVF) Dysfunctional and Repeated Endovascular Procedures on AVF Intervention-Free Survival [Abstract]. J Am Soc Nephrol 34, 2023: 538.
8	Cromm K., Pham L.H.N., Jaha H., Schappert A., Liegl G., Fischer K.I., Fischer F., Rose M. CONVINCE Scientific Committee and CONVINCE Investigators	Self-Efficacy and Social Support Determine Self-Reported Health in Hemodialysis Patients	J Am Soc Nephrol 34, 2023: 13.	TH-OR42	Fresenius Medical Care	Read More	Cromm K., Pham L.H.N., Jaha H., Schappert A., Liegl G., Fischer K.I., Fischer F., Rose M. CONVINCE Scientific Committee and CONVINCE Investigators: Self-Efficacy and Social Support Determine Self-Reported Health in Hemodialysis Patients [Abstract]. J Am Soc Nephrol 34, 2023: 13.
9	Cromm K., Tunçel Ö.K., Humpert M., Pham L.H.N., Ríos T.D.l., Çelik Y., Agirbas I., Bedel T., Kaletas S., Asci G., Houts C.R., Wirth R., Ok E., Elbi H. DOPRO	Self- and Observer-Rated Computer-Based Cognitive Function and Abilities Tests Are Valid for Dialysis Patients	J Am Soc Nephrol 34, 2023: 516.	FR-PO416	Fresenius Medical Care	Read More	Cromm K., Tunçel Ö.K., Humpert M., Pham L.H.N., Ríos T.D.l., Çelik Y., Agirbas I., Bedel T., Kaletas S., Asci G., Houts C.R., Wirth R., Ok E., Elbi H. DOPRO: Self- and Observer-Rated Computer-Based Cognitive Function and Abilities Tests Are Valid for Dialysis Patients [Abstract]. J Am Soc Nephrol 34, 2023: 516.
10	Desai T., Lasky R.A., Malhotra K., Arens H.-J., Oliveira J.H. and Anger M.S.	Association of CKD-associated pruritis (CKDaP) with more sleep disorders, increased pain & worse fatigue in US hemodialysis patients	2023: Late-Breaking Clinical Trial	Late-Breaking Clinical Trial	Fresenius Medical Care	n.a.	Desai T., Lasky R.A., Malhotra K., Arens H.-J., Oliveira J.H. and Anger M.S.: Association of CKD-associated pruritis (CKDaP) with more sleep disorders, increased pain & worse fatigue in US hemodialysis patients [Abstract]. 2023
11	Dong Z., Zhang H., Wang L.-C., Ren S., Tisdale L., Han M., Mohib S., M. L.R., Prakash-Polet S., Douglas D., Starakiewicz P., Preddie D.C., Thijssen S. and Kotanko P.	Classification of Arteriovenous Access Aneurysm in Hemodialysis Patients Using Artificial Intelligence Application	J Am Soc Nephrol 34, 2023: 95-96.	TH-PO024	Azura Vascular Care, Renal Research Institute	Read More	Dong Z., Zhang H., Wang L.-C., Ren S., Tisdale L., Han M., Mohib S., M. L.R., Prakash-Polet S., Douglas D., Starakiewicz P., Preddie D.C., Thijssen S. and Kotanko P.: Classification of Arteriovenous Access Aneurysm in Hemodialysis Patients Using Artificial Intelligence Application [Abstract]. J Am Soc Nephrol 34, 2023: 95-96.
12	Ficociello L., Desai T., Oliveira J.H., Arens H.-J., Lasky R.A. and Anger M.S.	The association between pruritis severity and mental health-related quality of life in over 80,000 hemodialysis patients	2023: Late-Breaking Clinical Trial	Late-Breaking Clinical Trial	Fresenius Medical Care	n.a.	Ficociello L., Desai T., Oliveira J.H., Arens H.-J., Lasky R.A. and Anger M.S.: The association between pruritis severity and mental health-related quality of life in over 80,000 hemodialysis patients [Abstract]. 2023
13	Ficociello L., Zhou M., Han H., Anger M.S. and Hymes J.L.	Relative Blood Volume Monitoring Using Crit-Line and Hospital Admissions: A Retrospective Analysis of over 25,000 Patients Across 330 Dialysis Clinics	J Am Soc Nephrol 34, 2023: 158.	TH-PO245	Fresenius Medical Care	Read More	Ficociello L., Zhou M., Han H., Anger M.S. and Hymes J.L.: Relative Blood Volume Monitoring Using Crit-Line and Hospital Admissions: A Retrospective Analysis of over 25,000 Patients Across 330 Dialysis Clinics [Abstract]. J Am Soc Nephrol 34, 2023: 158.
14	Fuertinger D.H., Joerg D.J., Ho K., Wang L.-C., Tisdale L., Ye X., Thijssen S. and Kotanko P.	Hemoglobin Variability in Hemodialysis Patients Improves Under Individualized Anemia Therapy	J Am Soc Nephrol 34, 2023: 358.	TH-PO955	Fresenius Medical Care, Renal Research Institute	Read More	Fuertinger D.H., Joerg D.J., Ho K., Wang L.-C., Tisdale L., Ye X., Thijssen S. and Kotanko P.: Hemoglobin Variability in Hemodialysis Patients Improves Under Individualized Anemia Therapy [Abstract]. J Am Soc Nephrol 34, 2023: 358.
15	Gorji H., Yang J.W., Hannan M., He J., Miller L.M., Mathew A.V., Seliger S.L., Tamura M., Mehta R., Kotanko P., Ix J.H., Rhee E.P., Malhotra R. CRIC Writing Group	Kynurenine Metabolism and Neurocognition in CKD: CRIC Study	J Am Soc Nephrol 34, 2023: 390-391.	TH-PO1066	Renal Research Institute	Read More	Gorji H., Yang J.W., Hannan M., He J., Miller L.M., Mathew A.V., Seliger S.L., Tamura M., Mehta R., Kotanko P., Ix J.H., Rhee E.P., Malhotra R. CRIC Writing Group: Kynurenine Metabolism and Neurocognition in CKD: CRIC Study [Abstract]. J Am Soc Nephrol 34, 2023: 390-391.
16	Grobe N., Haq Z.S., Wang X., Cheng J., Dias G.F., Moore C., Piecha D., Kotanko P. and Ho C.-H.	Bisphenol Levels in Hemodialyzers	J Am Soc Nephrol 34, 2023: 881.	SA-PO562	Fresenius Medical Care	Read More	Grobe N., Haq Z.S., Wang X., Cheng J., Dias G.F., Moore C., Piecha D., Kotanko P. and Ho C.-H.: Bisphenol Levels in Hemodialyzers [Abstract]. J Am Soc Nephrol 34, 2023: 881.
17	Gross M., Gagel A.J. and Maierhofer A.	Is the Donnan Equilibrium Still Intact in High-Volume Hemodiafiltration?	J Am Soc Nephrol 34, 2023: 882.	SA-PO566	Fresenius Medical Care	Read More	Gross M., Gagel A.J. and Maierhofer A.: Is the Donnan Equilibrium Still Intact in High-Volume Hemodiafiltration? [Abstract]. J Am Soc Nephrol 34, 2023: 882.
18	Guedes M.H., Bessone M.I.D., Chan L., Quiroga A.E.D.l.T., Mermelstein A.E., Garcia-Garcia G., Peters V., Konings C., Guinsburg A.M., Moraes T.P., Kotanko P., Raimann J.G. and Uribarri J.	Creatinine Clearance Predicts Longitudinal Phosphate Levels Irrespective of Achieved Urea Kt/V: A Peritoneal Dialysis-MONDO Analysis	J Am Soc Nephrol 34, 2023: 907.	SA-PO649	Fresenius Medical Care, Renal Research Institute	Read More	Guedes M.H., Bessone M.I.D., Chan L., Quiroga A.E.D.l.T., Mermelstein A.E., Garcia-Garcia G., Peters V., Konings C., Guinsburg A.M., Moraes T.P., Kotanko P., Raimann J.G. and Uribarri J.: Creatinine Clearance Predicts Longitudinal Phosphate Levels Irrespective of Achieved Urea Kt/V: A Peritoneal Dialysis-MONDO Analysis [Abstract]. J Am Soc Nephrol 34, 2023: 907.
19	Guinsburg A.M., Bessone M.I.D., Caseiro J.M. and Hymes J.L.	Use of a Novel Machine Learning Tool (“DoWhy”) to Compare Mortality Risk Between High Volume Hemodiafiltration (HV-HDF) and Hemodialysis (HD) Patients in a Large Cohort from Latin America (LA)	J Am Soc Nephrol 34, 2023: 528.	FR-PO457	Fresenius Medical Care	Read More	Guinsburg A.M., Bessone M.I.D., Caseiro J.M. and Hymes J.L.: Use of a Novel Machine Learning Tool (“DoWhy”) to Compare Mortality Risk Between High Volume Hemodiafiltration (HV-HDF) and Hemodialysis (HD) Patients in a Large Cohort from Latin America (LA) [Abstract]. J Am Soc Nephrol 34, 2023: 528.
20	Han M., Wang L.-C., Ren S., Tisdale L., Dong Z., Nze C.R. and Kotanko P.	Long-COVID-19 in Hemodialysis Patients: A Prospective Study	J Am Soc Nephrol 34, 2023: 529-530.	FR-PO461	Renal Research Institute	Read More	Han M., Wang L.-C., Ren S., Tisdale L., Dong Z., Nze C.R. and Kotanko P.: Long-COVID-19 in Hemodialysis Patients: A Prospective Study [Abstract]. J Am Soc Nephrol 34, 2023: 529-530.
21	Henrie M.E. and Ho C.-H.	Endotoxin Retentive Performance of the Fresenius FX CorAL Dialyzer	J Am Soc Nephrol 34, 2023: 881.	SA-PO563	Fresenius Medical Care	Read More	Henrie M.E. and Ho C.-H.: Endotoxin Retentive Performance of the Fresenius FX CorAL Dialyzer [Abstract]. J Am Soc Nephrol 34, 2023: 881.
22	Jiao Y., Alejos B., Wolf M., Larkin J.W., Winter A., Chaudhuri S., Stauss-Grabo M., Usvyat L.A., Hymes J.L., Maddux F.W., Wheeler D.C., Stenvinkel P., Floege J. On Behalf of the INSPIRE Core Group	Readmission After Gastrointestinal Bleeding Hospitalization Type in Dialysis Patients	J Am Soc Nephrol 34, 2023: 634-635.	FR-PO829	Fresenius Medical Care	Read More	Jiao Y., Alejos B., Wolf M., Larkin J.W., Winter A., Chaudhuri S., Stauss-Grabo M., Usvyat L.A., Hymes J.L., Maddux F.W., Wheeler D.C., Stenvinkel P., Floege J. On Behalf of the INSPIRE Core Group: Readmission After Gastrointestinal Bleeding Hospitalization Type in Dialysis Patients [Abstract]. J Am Soc Nephrol 34, 2023: 634-635.
23	Jiao Y., Alejos B., Wolf M., Larkin J.W., Winter A., Chaudhuri S., Stauss-Grabo M., Usvyat L.A., Hymes J.L., Maddux F.W., Wheeler D.C., Stenvinkel P., Floege J. On Behalf of the INSPIRE Core Group	Readmission After Gastrointestinal Bleeding Hospitalization in Dialysis Patients	J Am Soc Nephrol 34, 2023: 166.	TH-PO271	Fresenius Medical Care	Read More	Jiao Y., Alejos B., Wolf M., Larkin J.W., Winter A., Chaudhuri S., Stauss-Grabo M., Usvyat L.A., Hymes J.L., Maddux F.W., Wheeler D.C., Stenvinkel P., Floege J. On Behalf of the INSPIRE Core Group: Readmission After Gastrointestinal Bleeding Hospitalization in Dialysis Patients [Abstract]. J Am Soc Nephrol 34, 2023: 166.
24	Joerg D.J., Fuertinger D.H., Ho K., Wang L.-C., Tisdale L., Ye X., Thijssen S. and Kotanko P.	Efficiency and Efficacy of Anemia Therapy with Epoetin Beta: Results from a Randomized Controlled Trial of Therapy Software vs. Standard of Care	J Am Soc Nephrol 34, 2023: 362-363.	TH-PO970	Fresenius Medical Care, Renal Research Institute	Read More	Joerg D.J., Fuertinger D.H., Ho K., Wang L.-C., Tisdale L., Ye X., Thijssen S. and Kotanko P.: Efficiency and Efficacy of Anemia Therapy with Epoetin Beta: Results from a Randomized Controlled Trial of Therapy Software vs. Standard of Care [Abstract]. J Am Soc Nephrol 34, 2023: 362-363.
25	Kennedy J.P., Emal K., Werner J., Ho C.-H., Zawada A.M. and Boyington S.	Impact of Protein Fouling on Middle Molecule Removal During Initial Dialysis Phase	J Am Soc Nephrol 34, 2023: 878.	SA-PO553	Fresenius Medical Care	Read More	Kennedy J.P., Emal K., Werner J., Ho C.-H., Zawada A.M. and Boyington S.: Impact of Protein Fouling on Middle Molecule Removal During Initial Dialysis Phase [Abstract]. J Am Soc Nephrol 34, 2023: 878.
26	Kennedy J.P., Förster E., Saremi S., Theis L., Küng F., Delinski D., Xie W., Faust M. and Zawada A.M.	Hydrophilic Membrane Modification Improves Filtration Characteristics of Dialyzer Membranes	J Am Soc Nephrol 34, 2023: 878.	SA-PO554	Fresenius Medical Care	Read More	Kennedy J.P., Förster E., Saremi S., Theis L., Küng F., Delinski D., Xie W., Faust M. and Zawada A.M.: Hydrophilic Membrane Modification Improves Filtration Characteristics of Dialyzer Membranes [Abstract]. J Am Soc Nephrol 34, 2023: 878.
27	Kim B., Kutovoy G., Warzyn J., Lee M.A., Lasky R.A., Ficociello L. and Chatoth D.K.	Medication Management with Antihypertensive Agents and Associations with Peritoneal Dialysis Technique Failure in a Large, Retrospective Incident Cohort	J Am Soc Nephrol 34, 2023: 180.	TH-PO319	Fresenius Medical Care	Read More	Kim B., Kutovoy G., Warzyn J., Lee M.A., Lasky R.A., Ficociello L. and Chatoth D.K.: Medication Management with Antihypertensive Agents and Associations with Peritoneal Dialysis Technique Failure in a Large, Retrospective Incident Cohort [Abstract]. J Am Soc Nephrol 34, 2023: 180.
28	Kraus M.A., Lasky R.A., Ficociello L., Fisher E.C., Hussein U.T., Cabrera L.O., Thomas R. and Waiblinger P.	Provider Peritoneal Dialysis (PD) Education Can Increase Continuous Ambulatory Peritoneal Dialysis (CAPD) Utilization Without Increased Peritonitis	J Am Soc Nephrol 34, 2023: 901.	SA-PO629	Fresenius Medical Care	Read More	Kraus M.A., Lasky R.A., Ficociello L., Fisher E.C., Hussein U.T., Cabrera L.O., Thomas R. and Waiblinger P.: Provider Peritoneal Dialysis (PD) Education Can Increase Continuous Ambulatory Peritoneal Dialysis (CAPD) Utilization Without Increased Peritonitis [Abstract]. J Am Soc Nephrol 34, 2023: 901.
29	Lama S.K., Willetts J., Monaghan C., Chaudhuri S., Larkin J.W., Maddux F.W., Eneanya N.D., Kraus M.A., Sor M. and Usvyat L.A.	Race and Ethnicity Do Not Influence the Performance of Fistula Failure Machine Learning Model	J Am Soc Nephrol 34, 2023: 734.	SA-PO046	Azura Vascular Care, Fresenius Medical Care	Read More	Lama S.K., Willetts J., Monaghan C., Chaudhuri S., Larkin J.W., Maddux F.W., Eneanya N.D., Kraus M.A., Sor M. and Usvyat L.A.: Race and Ethnicity Do Not Influence the Performance of Fistula Failure Machine Learning Model [Abstract]. J Am Soc Nephrol 34, 2023: 734.
30	Larkin J.W., Griesshaber B., Erlenkoetter A., Krizsan M., Ronova P., Braun J. and Stauss-Grabo M.	Dialyzer Performance and Associations in Self-Reported Pruritis and Fatigue: Results from the eMPORA III Trial	J Am Soc Nephrol 34, 2023: 520.	FR-PO428	Fresenius Medical Care, Nephrocare	Read More	Larkin J.W., Griesshaber B., Erlenkoetter A., Krizsan M., Ronova P., Braun J. and Stauss-Grabo M.: Dialyzer Performance and Associations in Self-Reported Pruritis and Fatigue: Results from the eMPORA III Trial [Abstract]. J Am Soc Nephrol 34, 2023: 520.
31	Larkin J.W., Griesshaber B., Erlenkoetter A., Ronova P., Krizsan M., Braun J. and Stauss-Grabo M.	Clinical Performance and Patient-Reported Sleep Quality Associated with Dialyzer Types: Results from the eMPORA III Trial	J Am Soc Nephrol 34, 2023: 520.	FR-PO429	Fresenius Medical Care, Nephrocare	Read More	Larkin J.W., Griesshaber B., Erlenkoetter A., Ronova P., Krizsan M., Braun J. and Stauss-Grabo M.: Clinical Performance and Patient-Reported Sleep Quality Associated with Dialyzer Types: Results from the eMPORA III Trial [Abstract]. J Am Soc Nephrol 34, 2023: 520.
32	Larkin J.W., Griesshaber B., Erlenkoetter A., Ronova P., Krizsan M., Braun J. and Stauss-Grabo M.	Performance and Self-Perceived Restless Leg Syndrome Associated with Use of High-Flux Dialyzers: Results from the eMPORA III Trial	J Am Soc Nephrol 34, 2023: 631.	FR-PO819	Fresenius Medical Care, Nephrocare	Read More	Larkin J.W., Griesshaber B., Erlenkoetter A., Ronova P., Krizsan M., Braun J. and Stauss-Grabo M.: Performance and Self-Perceived Restless Leg Syndrome Associated with Use of High-Flux Dialyzers: Results from the eMPORA III Trial [Abstract]. J Am Soc Nephrol 34, 2023: 631.
33	Mermelstein A.E., Kovacevic T., Hymes J.L., Kotanko P. and Raimann J.G.	Hemoglobin (Hgb) Variability and Target Range in Hemodialysis (HD) Patients	J Am Soc Nephrol 34, 2023: 162.	TH-PO257	Fresenius Medical Care, Renal Research Institute	Read More	Mermelstein A.E., Kovacevic T., Hymes J.L., Kotanko P. and Raimann J.G.: Hemoglobin (Hgb) Variability and Target Range in Hemodialysis (HD) Patients [Abstract]. J Am Soc Nephrol 34, 2023: 162.
34	Monaghan C., Hanson M., Han H., Willetts J. and Usvyat L.A.	Impact of Nationwide Utilization of a Machine Learning Model to Identify Home Therapy Candidates	J Am Soc Nephrol 34, 2023: 102.	TH-PO046	Fresenius Medical Care	Read More	Monaghan C., Hanson M., Han H., Willetts J. and Usvyat L.A.: Impact of Nationwide Utilization of a Machine Learning Model to Identify Home Therapy Candidates [Abstract]. J Am Soc Nephrol 34, 2023: 102.
35	Nikam M., Chan C., Cheung Y.Y., Mooppil N., Li M. and Hymes J.L.	Hemodialysis Patient App Promotes Patient Engagement and May Improve Patient Outcomes Such as Hospitalisation and Phosphate Control	J Am Soc Nephrol 34, 2023: 64.	SA-OR19	Fresenius Medical Care	Read More	Nikam M., Chan C., Cheung Y.Y., Mooppil N., Li M. and Hymes J.L.: Hemodialysis Patient App Promotes Patient Engagement and May Improve Patient Outcomes Such as Hospitalisation and Phosphate Control [Abstract]. J Am Soc Nephrol 34, 2023: 64.
36	Pecoits P.G., Rigodon V., Jiao Y., Larkin J.W., Maddux F.W., Kotanko P., Pecoits-Filho R., Moraes T.P. and Guedes M.H.	Physical Quality of Life, Anemia, and Iron Stores Among Incident Peritoneal Dialysis Patients: Preliminary Findings from a Multinational Observational Study	J Am Soc Nephrol 34, 2023: 359-360.	TH-PO960	Fresenius Medical Care, Renal Research Institute	Read More	Pecoits P.G., Rigodon V., Jiao Y., Larkin J.W., Maddux F.W., Kotanko P., Pecoits-Filho R., Moraes T.P. and Guedes M.H.: Physical Quality of Life, Anemia, and Iron Stores Among Incident Peritoneal Dialysis Patients: Preliminary Findings from a Multinational Observational Study [Abstract]. J Am Soc Nephrol 34, 2023: 359-360.
37	Pham L.H.N., Cromm K., Zhang Y., Schappert A., Liegl G., Fischer K.I., Fischer F., Rose M. CONVINCE Scientific Committee and CONVINCE Investigators	Psychometric Validation of the CONVINCE Inter- and Intradialytic Symptoms Questionnaire	J Am Soc Nephrol 34, 2023: 517.	FR-PO418	Fresenius Medical Care	Read More	Pham L.H.N., Cromm K., Zhang Y., Schappert A., Liegl G., Fischer K.I., Fischer F., Rose M. CONVINCE Scientific Committee and CONVINCE Investigators: Psychometric Validation of the CONVINCE Inter- and Intradialytic Symptoms Questionnaire [Abstract]. J Am Soc Nephrol 34, 2023: 517.
38	Pinter J., Genser B., Chesnaye N.C., Pfeifer S., Mayne K.J., Stuard S., Moissl U., Kooman J., Jager K.J., Wanner C., Smyth B., Canaud B.J. European Clinical Database5 Study Group	The Impact of Chronic Fluid Overload, Water Imbalance (Tonicity), and Sodium Toxicity on Mortality of Hemodialysis Patients	J Am Soc Nephrol 34, 2023: 875.	SA-PO543	Fresenius Medical Care	Read More	Pinter J., Genser B., Chesnaye N.C., Pfeifer S., Mayne K.J., Stuard S., Moissl U., Kooman J., Jager K.J., Wanner C., Smyth B., Canaud B.J. European Clinical Database5 Study Group: The Impact of Chronic Fluid Overload, Water Imbalance (Tonicity), and Sodium Toxicity on Mortality of Hemodialysis Patients [Abstract]. J Am Soc Nephrol 34, 2023: 875.
39	Pulgar S.J., Panaccio M.P., Willetts J., Hussain M.A., Chaudhuri S., Usvyat L.A. and Niklason L.E.	Clinical and Demographic Characteristics Associated with Arteriovenous Access-Related Infections in US Patients Initiating Hemodialysis	J Am Soc Nephrol 34, 2023: 536.	FR-PO483	Fresenius Medical Care, Humacyte	Read More	Pulgar S.J., Panaccio M.P., Willetts J., Hussain M.A., Chaudhuri S., Usvyat L.A. and Niklason L.E.: Clinical and Demographic Characteristics Associated with Arteriovenous Access-Related Infections in US Patients Initiating Hemodialysis [Abstract]. J Am Soc Nephrol 34, 2023: 536.
40	Raimann J.G., Mermelstein A.E., Kovacevic T., Hymes J.L. and Kotanko P.	Hemoglobin (Hgb) Targets in Hemodialysis (HD) Patients: What Is the Optimal Target Range?	J Am Soc Nephrol 34, 2023: 361.	TH-PO965	Fresenius Medical Care, Renal Research Institute	Read More	Raimann J.G., Mermelstein A.E., Kovacevic T., Hymes J.L. and Kotanko P.: Hemoglobin (Hgb) Targets in Hemodialysis (HD) Patients: What Is the Optimal Target Range? [Abstract]. J Am Soc Nephrol 34, 2023: 361.
41	Rigodon V., Guedes M.H., Tiv S., Vincent Peters, Jiao Y., Winter A., Wolf M., Croft K., Carioni P., Chaudhuri S., Rancati M., Bessone M.I.D., Ye X., Larkin J.W., Nikam M., Toffelmire E.B., Konings C., Stuard S., Guinsburg A.M., Hymes J.L., Pecoits-Filho R., Moraes T.P., Hussein R.H., Tonelli M., Kotanko P. From the MONDO Investigators	Characteristics of Global Dialysis Data from Multiple Providers in the New MONitoring Dialysis Outcomes (MONDO) Dataset	J Am Soc Nephrol 34, 2023: 175-176.	TH-PO304	Fresenius Medical Care, Renal Research Institute	Read More	Rigodon V., Guedes M.H., Tiv S., Vincent Peters, Jiao Y., Winter A., Wolf M., Croft K., Carioni P., Chaudhuri S., Rancati M., Bessone M.I.D., Ye X., Larkin J.W., Nikam M., Toffelmire E.B., Konings C., Stuard S., Guinsburg A.M., Hymes J.L., Pecoits-Filho R., Moraes T.P., Hussein R.H., Tonelli M., Kotanko P. From the MONDO Investigators: Characteristics of Global Dialysis Data from Multiple Providers in the New MONitoring Dialysis Outcomes (MONDO) Dataset [Abstract]. J Am Soc Nephrol 34, 2023: 175-176.
42	Rigodon V., Hartley B., Pecoits P.G., Jiao Y., Larkin J.W., Neri L., Usvyat L.A., Maddux F.W., Kooman J., Kotanko P., Pecoits-Filho R., Moraes T.P. and Guedes M.H.	Higher Iron Deficiency Rates Among Incident Peritoneal Dialysis Patients Without Anemia in Brazil and United States	J Am Soc Nephrol 34, 2023: 908.	SA-PO652	Fresenius Medical Care, Renal Research Institute	Read More	Rigodon V., Hartley B., Pecoits P.G., Jiao Y., Larkin J.W., Neri L., Usvyat L.A., Maddux F.W., Kooman J., Kotanko P., Pecoits-Filho R., Moraes T.P. and Guedes M.H.: Higher Iron Deficiency Rates Among Incident Peritoneal Dialysis Patients Without Anemia in Brazil and United States [Abstract]. J Am Soc Nephrol 34, 2023: 908.
43	Rigodon V., Pecoits P.G., Larkin J.W., Jiao Y., Usvyat L.A., Maddux F.W., Kotanko P., Pecoits-Filho R., Moraes T.P. and Guedes M.H.	Profiles of Iron and Anemia Indices and Associations in Mental Health Among Incident Peritoneal Dialysis Patients in Brazil and the United States	J Am Soc Nephrol 34, 2023: 908.	SA-PO651	Fresenius Medical Care, Renal Research Institute	Read More	Rigodon V., Pecoits P.G., Larkin J.W., Jiao Y., Usvyat L.A., Maddux F.W., Kotanko P., Pecoits-Filho R., Moraes T.P. and Guedes M.H.: Profiles of Iron and Anemia Indices and Associations in Mental Health Among Incident Peritoneal Dialysis Patients in Brazil and the United States [Abstract]. J Am Soc Nephrol 34, 2023: 908.
44	Rose M., Fischer F., Liegl G., Strippoli G., Hockham C., Vernooij R.W., Barth C.M., Canaud B.J., Covic A., Cromm K., Davenport A., Fischer K.I., Hegbrant J.B., Jaha H., Schappert A., Török M., Bots M.L. and Blankenstijn P.J.	Patient-Reported Health Status of Adults with Kidney Failure Receiving Hemodiafiltration versus Hemodialysis – Results from the CONVINCE Randomized Controlled Clinical Trial	2023: Late-Breaking Clinical Trial	Late-Breaking Clinical Trial	Fresenius Medical Care	n.a.	Rose M., Fischer F., Liegl G., Strippoli G., Hockham C., Vernooij R.W., Barth C.M., Canaud B.J., Covic A., Cromm K., Davenport A., Fischer K.I., Hegbrant J.B., Jaha H., Schappert A., Török M., Bots M.L. and Blankenstijn P.J.: Patient-Reported Health Status of Adults with Kidney Failure Receiving Hemodiafiltration versus Hemodialysis – Results from the CONVINCE Randomized Controlled Clinical Trial [Abstract]. 2023
45	Ruessmann D., Oliveira J.H., Arens H.-J., Lasky R.A., Anger M.S. and Ficociello L.	Real-World Experience with Difelikeaflin to Treat CKD-Associated Pruritus at a Large Dialysis Organization	J Am Soc Nephrol 34, 2023: 519.	FR-PO425	Fresenius Medical Care	Read More	Ruessmann D., Oliveira J.H., Arens H.-J., Lasky R.A., Anger M.S. and Ficociello L.: Real-World Experience with Difelikeaflin to Treat CKD-Associated Pruritus at a Large Dialysis Organization [Abstract]. J Am Soc Nephrol 34, 2023: 519.
46	Schappacher-Tilp G., Kaehling N., Teiniker E. and Kotanko P.	Interactive Simulator for Model-Based Predictions of Parathyroid Hormone (PTH) Levels in Hemodialysis Patients	J Am Soc Nephrol 34, 2023: 124.	TH-PO129	Renal Research Institute	Read More	Schappacher-Tilp G., Kaehling N., Teiniker E. and Kotanko P.: Interactive Simulator for Model-Based Predictions of Parathyroid Hormone (PTH) Levels in Hemodialysis Patients [Abstract]. J Am Soc Nephrol 34, 2023: 124.
47	Scoggins T., Mccarley P., Rivenbark A.S., Stennett A., Ash B.S., Yatsuhashi K., Becker K.Y., Monaghan C., Chaudhuri S., Larkin J.W. and Hymes J.L.	Clinic-Level Fluid Quality Score Associates with Fluid Overload Hospitalizations	J Am Soc Nephrol 34, 2023: 924-925.	SA-PO707	Fresenius Medical Care	Read More	Scoggins T., Mccarley P., Rivenbark A.S., Stennett A., Ash B.S., Yatsuhashi K., Becker K.Y., Monaghan C., Chaudhuri S., Larkin J.W. and Hymes J.L.: Clinic-Level Fluid Quality Score Associates with Fluid Overload Hospitalizations [Abstract]. J Am Soc Nephrol 34, 2023: 924-925.
48	Sieck N.E., Song H., Raimann J.G., Kotanko P., Maddux F.W., He H. and Sapkota A.	Risk of Hospitalization and Mortality Following Extreme Heat Events in Patients Undergoing In-Center Hemodialysis in the Western United States	J Am Soc Nephrol 34, 2023: 530.	FR-PO462	Fresenius Medical Care, Renal Research Institute	Read More	Sieck N.E., Song H., Raimann J.G., Kotanko P., Maddux F.W., He H. and Sapkota A.: Risk of Hospitalization and Mortality Following Extreme Heat Events in Patients Undergoing In-Center Hemodialysis in the Western United States [Abstract]. J Am Soc Nephrol 34, 2023: 530.
49	Song H., Sieck N.E., Raimann J.G., Kotanko P., Maddux F.W., Ellicott E.A. and Sapkota A.	Exposure to Wildfire-Related Particulate Matter and Risk of Hospitalization and Mortality Among Hemodialysis Patients	J Am Soc Nephrol 34, 2023: 15.	TH-OR50	Fresenius Medical Care, Renal Research Institute	Read More	Song H., Sieck N.E., Raimann J.G., Kotanko P., Maddux F.W., Ellicott E.A. and Sapkota A.: Exposure to Wildfire-Related Particulate Matter and Risk of Hospitalization and Mortality Among Hemodialysis Patients [Abstract]. J Am Soc Nephrol 34, 2023: 15.
50	Spitzenbergen B.A.K.V., Dias G.F., Grobe N., Moreno-Amaral A.N. and Kotanko P.	3-Carboxy-4-Methyl-5-Propyl-2-Furanpropionate (CMPF), an Endogenous Protein-Bound Uremic Solute, Renders Erythrocyte Osmotically More Fragile, Possibly Through a Piezo1 Pathway	J Am Soc Nephrol 34, 2023: 357.	TH-PO950	Renal Research Institute	Read More	Spitzenbergen B.A.K.V., Dias G.F., Grobe N., Moreno-Amaral A.N. and Kotanko P.: 3-Carboxy-4-Methyl-5-Propyl-2-Furanpropionate (CMPF), an Endogenous Protein-Bound Uremic Solute, Renders Erythrocyte Osmotically More Fragile, Possibly Through a Piezo1 Pathway [Abstract]. J Am Soc Nephrol 34, 2023: 357.
51	Titapiccolo J.I., Bellocchio F., Stuard S., Usvyat L.A. and Neri L.	Quality-of-Life Penalty Associated with Anemia of CKD in a Large Sample of Dialysis Patients	J Am Soc Nephrol 34, 2023: 516.	FR-PO414	Fresenius Medical Care	Read More	Titapiccolo J.I., Bellocchio F., Stuard S., Usvyat L.A. and Neri L.: Quality-of-Life Penalty Associated with Anemia of CKD in a Large Sample of Dialysis Patients [Abstract]. J Am Soc Nephrol 34, 2023: 516.
52	Titapiccolo J.I., Bellocchio F., Stuard S., Usvyat L.A. and Neri L.	Association Between Vascular Access Type and Health-Related Quality of Life	J Am Soc Nephrol 34, 2023: 533.	FR-PO472	Fresenius Medical Care	Read More	Titapiccolo J.I., Bellocchio F., Stuard S., Usvyat L.A. and Neri L.: Association Between Vascular Access Type and Health-Related Quality of Life [Abstract]. J Am Soc Nephrol 34, 2023: 533.
53	Wang L.-C., Zhang H., Ginsberg N. and Kotanko P.	Application of Large Language Models such as ChatGPT to Support Nutritional Recommendations for Dialysis Patients	J Am Soc Nephrol 34, 2023: 91.	TH-PO008	Fresenius Dialysis Centers, Renal Research Institute	Read More	Wang L.-C., Zhang H., Ginsberg N. and Kotanko P.: Application of Large Language Models such as ChatGPT to Support Nutritional Recommendations for Dialysis Patients [Abstract]. J Am Soc Nephrol 34, 2023: 91.
54	Wang X., Zaidi S.S., Chan C., Cheung Y.Y., Grobe N., Kotanko P., Mitra S. and Nikam M.	Metabolomic Analysis of Plasma Samples Collected Before Arteriovenous Fistula Creation Reveals Metabolome Clusters that Associate with Maturation Outcomes	J Am Soc Nephrol 34, 2023: 537.	FR-PO486	Fresenius Medical Care, Renal Research Institute	Read More	Wang X., Zaidi S.S., Chan C., Cheung Y.Y., Grobe N., Kotanko P., Mitra S. and Nikam M.: Metabolomic Analysis of Plasma Samples Collected Before Arteriovenous Fistula Creation Reveals Metabolome Clusters that Associate with Maturation Outcomes [Abstract]. J Am Soc Nephrol 34, 2023: 537.
55	Wolf M., Jiao Y., Croft K., Bessone M.I.D., Rancati M., Winter A., Carioni P., Chaudhuri S., Neri L., Singh K., Nikam M., Stuard S., Guinsburg A.M., Hymes J.L., Usvyat L.A., Larkin J.W., Maddux F.W. Apollo DB Team	Apollo DB: Characteristics of a Global Dialysis Database Across Major World Regions	J Am Soc Nephrol 34, 2023: 175.	TH-PO303	Fresenius Medical Care	Read More	Wolf M., Jiao Y., Croft K., Bessone M.I.D., Rancati M., Winter A., Carioni P., Chaudhuri S., Neri L., Singh K., Nikam M., Stuard S., Guinsburg A.M., Hymes J.L., Usvyat L.A., Larkin J.W., Maddux F.W. Apollo DB Team: Characteristics of a Global Dialysis Database Across Major World Regions [Abstract]. J Am Soc Nephrol 34, 2023: 175.
56	Zhang H., Preciado P., M. L.R., Kooman J., Sande F.v.d. and Kotanko P.	Interactions Between Intradialytic Central Venous Oxygen Saturation, Ultrafiltration Rate, and All-Cause Mortality in Maintenance Hemodialysis Patients	J Am Soc Nephrol 34, 2023: 171.	TH-PO288	Renal Research Institute	Read More	Zhang H., Preciado P., M. L.R., Kooman J., Sande F.v.d. and Kotanko P.: Interactions Between Intradialytic Central Venous Oxygen Saturation, Ultrafiltration Rate, and All-Cause Mortality in Maintenance Hemodialysis Patients [Abstract]. J Am Soc Nephrol 34, 2023: 171.
57	Zhang Y., Winter A., Carioni P., Alejos B., Usvyat L.A. and Maddux F.W.	Real-world effectiveness of hemodialysis modalities	2023: Late-Breaking Clinical Trial	Late-Breaking Clinical Trial	Fresenius Medical Care	n.a.	Zhang Y., Winter A., Carioni P., Alejos B., Usvyat L.A. and Maddux F.W.: Real-world effectiveness of hemodialysis modalities [Abstract]. 2023
58	Zhou M., Ficociello L., Anger M.S. and Kwoh C.	Management of Serum Phosphorus over a Six-Month Follow-Up in Home Hemodialysis Patients Prescribed Sucroferric Oxyhydroxide as Part of Routine Clinical Care	J Am Soc Nephrol 34, 2023: 128.	TH-PO142	Fresenius Medical Care	Read More	Zhou M., Ficociello L., Anger M.S. and Kwoh C.: Management of Serum Phosphorus over a Six-Month Follow-Up in Home Hemodialysis Patients Prescribed Sucroferric Oxyhydroxide as Part of Routine Clinical Care [Abstract]. J Am Soc Nephrol 34, 2023: 128.
59	Zhou M., Willetts J., Ficociello L., Eneanya N.D. and Usvyat L.A.	Sociodemographic Characteristics of Hemodialysis Patients Prescribed Sucroferric Oxyhydroxide and Other Phosphate Binders	J Am Soc Nephrol 34, 2023: 734-735.	SA-PO048	Fresenius Medical Care	Read More	Zhou M., Willetts J., Ficociello L., Eneanya N.D. and Usvyat L.A.: Sociodemographic Characteristics of Hemodialysis Patients Prescribed Sucroferric Oxyhydroxide and Other Phosphate Binders [Abstract]. J Am Soc Nephrol 34, 2023: 734-735.
60	Zhu F. and Kotanko P.	Estimation of Fluid Overload in Hemodialysis Patients Using Leg Bioimpedance	J Am Soc Nephrol 34, 2023: 159.	TH-PO248	Renal Research Institute	Read More	Zhu F. and Kotanko P.: Estimation of Fluid Overload in Hemodialysis Patients Using Leg Bioimpedance [Abstract]. J Am Soc Nephrol 34, 2023: 159.
61	Zhu F., M. L.R., Tisdale L., Yi J., Fischer K., Plahey K., Chamney P.W., Schiller B. and Kotanko P.	Dynamical Monitoring of “Intraperitoneal” Pressures by a Sensor Integrated into a Peritoneal Dialysis (PD) Cycler: Proof-of-Principle Bench Studies	J Am Soc Nephrol 34, 2023: 176.	TH-PO307	Fresenius Medical Care, Renal Research Institute	Read More	Zhu F., M. L.R., Tisdale L., Yi J., Fischer K., Plahey K., Chamney P.W., Schiller B. and Kotanko P.: Dynamical Monitoring of “Intraperitoneal” Pressures by a Sensor Integrated into a Peritoneal Dialysis (PD) Cycler: Proof-of-Principle Bench Studies [Abstract]. J Am Soc Nephrol 34, 2023: 176.
62	Zhu F., Raimann J.G., Moissl U., Abbas S.R., Chamney P.W., Thijssen S. and Kotanko P.	Estimation of Absolute Blood Volume in Hemodialysis Patients Using Bioimpedance Spectroscopy	J Am Soc Nephrol 34, 2023: 159.	TH-PO247	Fresenius Medical Care, Renal Research Institute	Read More	Zhu F., Raimann J.G., Moissl U., Abbas S.R., Chamney P.W., Thijssen S. and Kotanko P.: Estimation of Absolute Blood Volume in Hemodialysis Patients Using Bioimpedance Spectroscopy [Abstract]. J Am Soc Nephrol 34, 2023: 159.
63	Zoccali C., D’Arrigo G., Gori M., Tripepi G., Mallamaci F. On Behalf of MAURO Study Group	Metabolic Acidosis and CKD Progression	J Am Soc Nephrol 34, 2023: 660.	FR-PO919	Renal Research Institute	Read More	Zoccali C., D’Arrigo G., Gori M., Tripepi G., Mallamaci F. On Behalf of MAURO Study Group: Metabolic Acidosis and CKD Progression [Abstract]. J Am Soc Nephrol 34, 2023: 660.
64	Zoccali C., Torino C., Tripepi R., Tripepi G., Mallamaci F. On Behalf of the LUST Workgroup	Legacy Effect of a Lung-Ultrasound Intervention on the Risk for Death and Cardiovascular Events in Dialysis Patients	J Am Soc Nephrol 34, 2023: 160.	TH-PO250	Renal Research Institute	Read More	Zoccali C., Torino C., Tripepi R., Tripepi G., Mallamaci F. On Behalf of the LUST Workgroup: Legacy Effect of a Lung-Ultrasound Intervention on the Risk for Death and Cardiovascular Events in Dialysis Patients [Abstract]. J Am Soc Nephrol 34, 2023: 160.